MIZUHO MEDY CO.,LTD.

4595・Standard Market・Pharmaceuticals

Official website

MIZUHO MEDY CO.,LTD.

4595・Standard Market・Pharmaceuticals

Official website

MIZUHO MEDY CO.,LTD.4595

Reference Indicators

Market Cap

318¥100M

P/E (Forecast)

9.9x

P/B

1.7x

Dividend Yield (Forecast)

6.00%

ROE

19.0%

EV/EBITDA

4.3x

Financial Summary

Unit: ¥M

Item	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Net Sales	13,137	17,581	10,989	11,429	11,260
Gross Profit	9,903	14,100	8,074	8,083	7,819
SG&A Expenses	2,953	2,995	2,922	3,166	3,172
Operating Income	6,698	11,104	5,151	4,917	4,646
Non-operating Income	4	16	140	250	108
Non-operating Expenses	2	50	—	—	18
Ordinary Income	6,700	11,070	5,292	5,167	4,736
Extraordinary Income	124	—	—	—	—
Pre-tax Income	6,824	11,070	5,292	5,167	4,736
Income Taxes	2,007	3,232	1,518	1,393	1,310
Net Income	4,816	7,838	3,774	3,773	3,425
EBITDA	6,871	11,290	5,347	5,145	4,912
Gross Margin	75.4%	80.2%	73.5%	70.7%	69.4%
Operating Margin	51.0%	63.2%	46.9%	43.0%	41.3%
ROA	39.5%	41.0%	19.9%	18.2%	15.3%
ROE	81.6%	70.3%	25.2%	22.9%	19.0%